Healthcare - Biotechnology - NASDAQ - US
$ 1.38
-13.2 %
$ 190 M
Market Cap
-3.94
P/E
INCOME STATEMENT
0
REVENUE
-50.4 M
OPERATING INCOME
-42.5 M
NET INCOME
EFFICIENCY
Earnings Waterfall
Compass Therapeutics, Inc.
| Revenue | 0 |
| Cost Of Revenue | 1.89 M |
| Gross Profit | -1.89 M |
| Operating Expenses | 48.5 M |
| Operating Income | -50.4 M |
| Other Expenses | -7.87 M |
| Net Income | -42.5 M |
Income Statement
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Mar-2020 | Mar-2019 | |
|---|---|---|---|---|---|---|
| REVENUE | ||||||
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 |
| GROSS PROFIT | ||||||
| Cost Of Revenue | 1.9 | 1.9 | 1.6 | 2.4 | 2.1 | 1.9 |
| Gross Profit | (1.9) | (1.9) | (1.6) | (2.4) | (2.1) | (1.9) |
| OPERATING INCOME | ||||||
| Operating Expenses | 48.5 | 41.7 | 31.3 | 27.8 | 34.1 | 38.3 |
| Selling, General and Administrative Expenses | 11.1 | 11.7 | 10.9 | 12.9 | 11.6 | 11.2 |
| Research and Development Expenses | 37.4 | 30.0 | 20.3 | 14.9 | 22.4 | 27.1 |
| Operating Income | (50.4) | (41.7) | (81.9) | (27.8) | (34.1) | (38.3) |
| PRE-TAX INCOME | ||||||
| Interest Income Expense | 0 | 2.4 | 0.4 | 0.9 | 1.2 | 0.8 |
| Total Other Income | 7.9 | 2.4 | (0.3) | (1.7) | (0.6) | 0.2 |
| Pre-Tax Income | (42.5) | (39.2) | (82.2) | (29.5) | (34.7) | (38.2) |
| NET INCOME | ||||||
| Tax Provision | 0 | (2.4) | 0.4 | 32 K | 91 K | 0.1 |
| Net Income | (42.5) | (36.8) | (82.6) | (29.5) | (34.7) | (38.3) |
| EPS | 0.33 | 0.35 | 1.31 | 0.96 | 0.67 | 0.73 |